YIH
RIGL icon

Y-Intercept (HK)’s Rigel Pharmaceuticals RIGL Stock Holding History

Y-Intercept (HK)’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,803
Closed -$779K – 2090
2026
Q1 		$779K Buy
28,803
+546
+2% +$18.3K 0.01% 1118
2025
Q4 		$1.21M Buy
28,257
+4,440
+19% +$167K 0.03% 892
2025
Q3 		$675K Buy
+23,817
New +$712K 0.02% 1151
2022
Q4 		– Sell
-18,678
Closed -$220K – 1294
2022
Q3 		$220K Buy
+18,678
New +$253K 0.02% 794

Other funds holding RIGL

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return